[
  {
    "ts": "2025-11-21T14:06:00+00:00",
    "headline": "Here's How ANIP's Rare Disease Portfolio Is Driving Top-line Growth",
    "summary": "ANI Pharmaceuticals' rare disease surge, led by Cortrophin Gel, drives major 2025 revenue gains despite softer ophthalmology sales.",
    "url": "https://finance.yahoo.com/news/heres-anips-rare-disease-portfolio-140600264.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "bec8430b-6cf3-36a3-b672-9f9d8fd9b592",
      "content": {
        "id": "bec8430b-6cf3-36a3-b672-9f9d8fd9b592",
        "contentType": "STORY",
        "title": "Here's How ANIP's Rare Disease Portfolio Is Driving Top-line Growth",
        "description": "",
        "summary": "ANI Pharmaceuticals' rare disease surge, led by Cortrophin Gel, drives major 2025 revenue gains despite softer ophthalmology sales.",
        "pubDate": "2025-11-21T14:06:00Z",
        "displayTime": "2025-11-21T14:06:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-anips-rare-disease-portfolio-140600264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ANIP"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T15:30:00+00:00",
    "headline": "Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3?",
    "summary": "Ironwood gains momentum as rising U.S. demand for Linzess drives strong profit growth during the third quarter.",
    "url": "https://finance.yahoo.com/news/linzess-continue-aid-irwds-top-153000170.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "15c6989b-eda2-3361-a519-d9eaa809751d",
      "content": {
        "id": "15c6989b-eda2-3361-a519-d9eaa809751d",
        "contentType": "STORY",
        "title": "Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3?",
        "description": "",
        "summary": "Ironwood gains momentum as rising U.S. demand for Linzess drives strong profit growth during the third quarter.",
        "pubDate": "2025-11-21T15:30:00Z",
        "displayTime": "2025-11-21T15:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4f278dd92e23382650f269f90b5fb0c9",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F2U5YD8Wk7dT2wbWDBGXZg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f278dd92e23382650f269f90b5fb0c9.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/565G_.yU2UMQcw4nHig1TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f278dd92e23382650f269f90b5fb0c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/linzess-continue-aid-irwds-top-153000170.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/linzess-continue-aid-irwds-top-153000170.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "4503.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T15:19:00+00:00",
    "headline": "Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI",
    "summary": "LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.",
    "url": "https://finance.yahoo.com/news/healthcare-etfs-buy-big-pharma-151900701.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e7a80a4d-e66f-3837-b0cc-f5e2c1404054",
      "content": {
        "id": "e7a80a4d-e66f-3837-b0cc-f5e2c1404054",
        "contentType": "STORY",
        "title": "Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI",
        "description": "",
        "summary": "LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.",
        "pubDate": "2025-11-21T15:19:00Z",
        "displayTime": "2025-11-21T15:19:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/57.Lfvcoa8N_9pHFAUTShA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/39hBnd4FwGlouiqapgQKxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-etfs-buy-big-pharma-151900701.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-etfs-buy-big-pharma-151900701.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T19:37:45+00:00",
    "headline": "Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.",
    "summary": "Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more patients.",
    "url": "https://www.investors.com/news/technology/biotech-stocks-antibody-drug-conjugates-adcs-cancer-treatment-chemotherapy/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "f9b725a0-70ec-3d7c-b6ad-57019bb16362",
      "content": {
        "id": "f9b725a0-70ec-3d7c-b6ad-57019bb16362",
        "contentType": "STORY",
        "title": "Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.",
        "description": "",
        "summary": "Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more patients.",
        "pubDate": "2025-11-21T19:37:45Z",
        "displayTime": "2025-11-21T19:37:45Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f9b725a0-70ec-3d7c-b6ad-57019bb16362/fighting-cancer-with-smart.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/237de1ebdaae3c2cd271d4caaa7f01d0",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jpyb2VHadwLpdm8jAVYfhQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/237de1ebdaae3c2cd271d4caaa7f01d0.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SeUW7GFT6kjZe0KkGlgiZA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/237de1ebdaae3c2cd271d4caaa7f01d0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/biotech-stocks-antibody-drug-conjugates-adcs-cancer-treatment-chemotherapy/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GMAB"
            },
            {
              "symbol": "GNMSF"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "ROG.SW"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T21:20:00+00:00",
    "headline": "Top Research Reports for JPMorgan Chase, Netflix & AbbVie",
    "summary": "JPMorgan's year-to-date gains, NII growth outlook and investment banking pipeline headline today's standout Zacks research picks.",
    "url": "https://finance.yahoo.com/news/top-research-reports-jpmorgan-chase-212000782.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e07f7325-071e-343b-8c95-7d59b39d5d06",
      "content": {
        "id": "e07f7325-071e-343b-8c95-7d59b39d5d06",
        "contentType": "STORY",
        "title": "Top Research Reports for JPMorgan Chase, Netflix & AbbVie",
        "description": "",
        "summary": "JPMorgan's year-to-date gains, NII growth outlook and investment banking pipeline headline today's standout Zacks research picks.",
        "pubDate": "2025-11-21T21:20:00Z",
        "displayTime": "2025-11-21T21:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ad97b76886f41f101440f2b78f94058a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aNv5UtO9WBEt6VxttOa26g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ad97b76886f41f101440f2b78f94058a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UZyY47MTqA30wcXCF4p_Ig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ad97b76886f41f101440f2b78f94058a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-research-reports-jpmorgan-chase-212000782.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-research-reports-jpmorgan-chase-212000782.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "ALL"
            },
            {
              "symbol": "ALL-PH"
            },
            {
              "symbol": "ALL-PI"
            },
            {
              "symbol": "ALL-PJ"
            },
            {
              "symbol": "RSG"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "OVBC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T23:51:00+00:00",
    "headline": "AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to",
    "url": "https://finance.yahoo.com/news/abbvie-biogen-biomarin-pharmaceutical-dexcom-235100264.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "15929d4c-b37e-3fd3-bc4e-8ad4ace5531e",
      "content": {
        "id": "15929d4c-b37e-3fd3-bc4e-8ad4ace5531e",
        "contentType": "STORY",
        "title": "AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to",
        "pubDate": "2025-11-21T23:51:00Z",
        "displayTime": "2025-11-21T23:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ABBV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K222hrzb0FJJlqrDZzsz7w--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cD3IChyAhZhexmnMXW7jMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-biogen-biomarin-pharmaceutical-dexcom-235100264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-biogen-biomarin-pharmaceutical-dexcom-235100264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "BMRN"
            },
            {
              "symbol": "DXCM"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]